Insights

Sophie Wang to Moderate at Consero IP Forum for Life Sciences

Sophie Wang will moderate the panel, "Keeping Litigation and Prosecution Aligned" at Consero's IP Forum for Life Sciences on Wednesday, December 4th at 2:30 p.m.

Choate Ranks Highly in Benchmark Litigation 2025

Choate earned high rankings in Benchmark Litigation’s 2025 annual survey of the top attorneys and law firms in the United States.

Sophie Wang to Moderate Biologics and Biosimilars Panel at Patent Litigation Summit

Sophie Wang will moderate the panel, "Navigating the Complexities of BPCIA Litigation in the Biologics and Biosimilars Landscape" at the North America Pharma & Biotech Patent Litigation Summit on Tuesday, October 29th at 2:00 p.m.

Sophie Wang Quoted in Law360 on Cellect Case

Sophie Wang is quoted in the June 21 Law360 article, “Drug Cos., IP Attys Back Cellect In High Court Efforts.”

Choate Lawyers and Practice Groups Recognized by Chambers 2024

The 2024 edition of Chambers USA Guide to America’s Leading Lawyers for Business recognized 34 Choate attorneys as leading counsel in their respective fields, with seven receiving Band 1 rankings.

Choate Receives Significant Accolades in 2024 IAM Patent 1000

Choate has been recognized by IAM Patent 1000: The World’s Leading Patent Professionals 2024.

Salix v. Norwich Patent Infringement Opinion and the Implications of a Post-Trial ANDA Amendment and Section 8 Carveout

In this episode of our Life Sciences Insights podcast series, Sophie Wang and Madison Garrett discuss the Federal Circuit’s recent opinion in a patent infringement case between Salix Pharmaceuticals and Norwich Pharmaceuticals.

Sophie Wang Appointed Chair of the AIPLA Amicus Committee

Sophie Wang, a partner in Choate’s Life Sciences and Intellectual Property Litigation groups, has been appointed to serve as Chair of the American Intellectual Property Law Association (AIPLA) Amicus Committee until October 2025.

Sophie Wang Quoted in Law360 on Double Patenting Case

Sophie Wang is quoted in a recent Law360 article, “Full Fed. Circ. Warned Of Fallout From Double Patenting Case.”